Cohance Lifesciences shares fall after company sells its assets

Posted by on


Company has entered into an agreement with Chromo Laboratories India Private Limited for the sale of the assets pertaining to its standalone Clinical
Research and Bio-analytical unit) for a consideration of ₹16 crore.

Comments

Post a Comment